Nasdaq 100 constituents show mixed performance: pharmaceutical, semiconductor, and aerospace stocks gain, while Axon and Microchip lead declines.
Original headline纳斯达克 100 成分股涨跌分化：医药、半导体及航天股走强，Axon 与微芯科技领跌
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Nasdaq-100 constituents traded sharply mixed on November 6, with Moderna (MRNA) up 9.34%, AMD up 8.84%, Airbnb (ABNB) up 8.71%, Lam Research (LRCX) up 8.53% and Rocket Lab (RKLB) up 6.94%, while Axon Enterprise (AXON) fell 18.10%, Microchip Technology (MCHP) dropped 13.38%, Monster Beverage (MNST) lost 4.83%, Intuit (INTU) slid 4.66% and Dexcom (DXCM) fell 4.10%. The split reflects rotation into semiconductors, mRNA medicines and space names and away from law-enforcement tech, microcontroller chips and some software and consumer stocks. Axon's 18% plunge was the session's largest decliner among the group, while AMD and Lam Research led chip-equipment and design gains. Investors will watch whether the semiconductor and aerospace strength persists and whether Axon and Microchip can stabilize after their double-digit drops.
Muhabbit's AI wrote this summary in its own words from TechFlow's report and translated it from Chinese. It can get details wrong, so check the source.
Named in this story
Moderna (MRNA), Microchip Technology (MCHP), Axon Enterprise (AXON), Advanced Micro Devices (AMD), Lam Research, Rocket Lab (RKLB), Airbnb (ABNB), DexCom
A linked name opens that asset's sentiment page.